Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader of Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center, shared a post on X:
“20 years of collaboration and friendship.
Vincent Rajkumar and I have done numerous studies together on myeloma precursor disease.
During ASH we always meet up 1:1 and chat for 1-2 hrs.
Friendship goes beyond work.”
More posts featuring C. Ola Landgren.